Conditions: Schizophrenia
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 284
Healthy volunteers: no

Brief summary:
The study evaluates the long term safety and efficacy of SM-13496 in patients with schizophrenia.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: SM-13496
Intervention descriptions: intervention 1: 40 or 80 mg once daily orally

Protocol document: